January 17, 2019

A Mixed Bag For Lipocine, Inc.

Lipocine Inc (LPCN) slumped after opening sharply higher today. The stock rallied in the pre-market due to the company releasing a report detailing apparently positive indications for LPCN for its potential in the treatment of liver fat in hypogonadal males. However, biotech columnist Adam Feuerstein voiced negative comments, stating that he believes the study was not conducted properly and therefore questions the validity of the results. Here’s a recap.

about the author:

Mike Patton

Mike Patton took the leap into the markets beginning as a commodities broker in 2005, where he was responsible for identifying trading opportunities and executing trades on behalf of clients. After years as a broker he made the jump to education by joining the team at Trading Advantage, now Prosper Trading Academy.

Read Similar Articles

April 6, 2026

Q1 Earnings Season Preview: What To Expect

As we start a brand new quarter in 2026, it also resets the earnings cycle for companies to report their quarterly results — and I believe that Q1 Earnings Season could have a lot in store. Q4 earnings season at the start of the year gave traders a lot to process. It also set the […]

Read Article
April 3, 2026

March 2026 Jobs Report: The Good, Bad, & Unexpected

The March 2026 Jobs Report was among the most anticipated ones in recent memory. Right now, the economy is being shaped by a number of factors: These current circumstances — combined with February’s bad jobs report — had traders preparing for the worst. Fortunately, the March 2026 Jobs Report looked much better than expected…at least […]

Read Article
January 21, 2026

Could Penny Stocks Be The Big Play In 2026?

Written By: Howard Greenberg As everyday traders put their trading plans into action for 2026, penny stocks might not be on many of their radars. It’s totally understandable why penny stocks may not appeal to the more calculated seasoned traders. Their reputations for susceptibility to manipulation, extreme volatility, and low liquidity make them way too […]

Read Article

Read Similar Articles

June 8, 2026

Nvidia’s Demand Problem Could Be A Trader’s Opportunity

Nvidia (NVDA) pulled back from its highs. That’s what a lot of traders are focusing on… but Charlie Moon doesn’t think the real story is the pullback. He believes it’s what’s driving demand on the other side of it. Jensen Huang recently made it clear that demand for Nvidia’s products is outpacing what they can […]

Read Article
June 7, 2026

The Week Ahead: Just A Minor Selloff, Or…?

Wall Street’s historic weekly run came to a halt, with stocks hit by a tech selloff and higher bond yields after a solid jobs report added to bets the Federal Reserve’s next interest-rate move will be a hike. The tech-heavy Nasdaq composite suffered its worst week in more than a year and the S&P 500 ended its […]

Read Article
June 5, 2026

Bitcoin Dethroned: Is a Replacement on the Horizon?

Bitcoin has been under serious pressure in 2026. Year-to-date, it’s down over 31%. When a prominent asset like Bitcoin falls this hard, one question always comes to mind: Is something else about to take its place? It’s a debate that resurfaces every time Bitcoin stumbles…and so far, its resilience has proven doubters wrong… But could […]

Read Article